Equine immune-mediated keratopathies.
Abstract: Immune mediated keratopathies (IMMKs) are a relatively commonly occurring group of heterogeneous corneal disorders. This paper describes the currently recognised clinical presentations of the IMMKs in the USA and in the UK. Although a clinical diagnosis is relatively straightforward in most cases, the specific aetiopathogeneses of the IMMKs remains elusive and largely speculative, but are thought to be based upon upregulated immunoreactivity in the normally immunologically passive cornea. Treatment protocols, both medical and surgical, are based primarily on collective clinical experience and are variably successful, and in some cases recurrence or refractoriness to treatment is possible.
Publication Date: 2010-10-14 PubMed ID: 20939164DOI: 10.1111/j.2042-3306.2010.tb05632.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research paper is about Immune-Mediated Keratopathies (IMMKs), which are common corneal disorders in horses, focusing on their clinical presentations, diagnoses, speculative causes, and treatment methods in the United States and the United Kingdom.
Clinical Presentations of IMMKs
- The paper begins by discussing the different clinical presentations of Immune-Mediated Keratopathies in horses both in the United States and the United Kingdom. Clinical presentations refer to the specific symptoms and signs exhibited by a disease in a patient. This information is critical for veterinarians to recognize the disorder and differentiate it from other corneal issues.
Aetiopathogeneses of IMMKs
- The paper then delves into the aetiopathogeneses of IMMKs, which refer to the causes and the development of the disease. However, the authors note that these are largely elusive and speculative due to the complexity of the diseases. The suggestive belief is that these disorders result from an upregulated immunoreactivity in the cornea, which is usually immunologically passive. The term upregulated immunoreactivity refers to an increase in immune response in the cornea, which can lead to inflammation and damage.
Treatment Protocols for IMMKs
- The research further explores the current treatment protocols for IMMKs, which are primarily based on collective clinical experience rather than strictly defined medical procedures. The settings of treatment can vary based on several factors including severity and type of the disorder, patient characteristics, and response to treatment. The treatments can either be medical, involving the use of drugs or other therapies, or surgical, involving invasive procedures to treat the disorder.
- However, treatment results can vary widely and some cases may exhibit recurrence or refractoriness, which means the disease will persist despite attempts to treat it. This shows the complexity and difficulty in managing these disorders effectively. Hence, further research needs to be conducted to establish more effective and reliable treatment methods.
Cite This Article
APA
Matthews A, Gilger B.
(2010).
Equine immune-mediated keratopathies.
Equine Vet J Suppl(37), 31-37.
https://doi.org/10.1111/j.2042-3306.2010.tb05632.x Publication
Researcher Affiliations
- McKenzie Bryson and Marshall, Kilmarnock, Scotland, UK.
MeSH Terms
- Animals
- Anti-Inflammatory Agents / therapeutic use
- Corneal Diseases / drug therapy
- Corneal Diseases / epidemiology
- Corneal Diseases / immunology
- Corneal Diseases / pathology
- Corneal Diseases / veterinary
- Horse Diseases / drug therapy
- Horse Diseases / epidemiology
- Horse Diseases / immunology
- Horse Diseases / pathology
- Horses
- Immunosuppressive Agents / therapeutic use
- United Kingdom / epidemiology
- United States / epidemiology
Citations
This article has been cited 2 times.- Cequier A, Sanz C, Rodellar C, Barrachina L. The Usefulness of Mesenchymal Stem Cells beyond the Musculoskeletal System in Horses. Animals (Basel) 2021 Mar 25;11(4).
- Preston JF, Mustikka MP, Priestnall SL, Dunkel B, Fischer MC. Clinical features and outcomes of horses presenting with presumed equine immune mediated keratitis to two veterinary hospitals in the United Kingdom and Finland: 94 cases (2009-2021). Equine Vet J 2025 May;57(3):598-610.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists